PUBLISHER: The Business Research Company | PRODUCT CODE: 2076988
PUBLISHER: The Business Research Company | PRODUCT CODE: 2076988
Biomedical refrigerators and freezers are purpose-built temperature-regulated storage systems designed for the preservation of biological specimens, vaccines, pharmaceuticals, and other temperature-sensitive materials. They are developed to sustain exact and consistent temperature ranges, often extending to ultra-low levels, to maintain the stability and integrity of stored substances. These systems are equipped with advanced functionalities such as uniform cooling distribution, continuous temperature tracking, and alarm systems to comply with strict regulatory and quality assurance requirements.
The primary product types of biomedical refrigerator and freezer include laboratory refrigerators, blood bank refrigerators, pharmacy refrigerators, ultra-low temperature freezers, plasma freezers, cryogenic freezers, vaccine storage refrigerators, explosion-proof refrigerators, chromatography refrigerators, and undercounter and benchtop units. Laboratory refrigerators refer to temperature-controlled storage systems used to preserve sensitive biomedical materials, vaccines, drugs, and biological samples under regulated conditions. They are categorized by mobility such as stationary floor-standing units, portable and transportable units, mobile cart-mounted systems, benchtop and countertop models, and transport and shipping containers and they are also categorized by temperature range such as 2°C to 8°C refrigerators, -20°C freezers, -40°C freezers, -80°C ultra-low freezers, and cryogenic freezers (-150°C and below). The various applications involved are vaccine storage, blood and plasma storage, drug storage, sample preservation, and biobanking and they are utilized by end users including hospitals, research laboratories, pharmacies, diagnostic centers, and other end users.
Tariffs are impacting the biomedical refrigerators and freezers market by increasing the cost of imported compressors, refrigerants, electronic control systems, and precision cooling components used in temperature-controlled storage units. This is affecting hospitals, research laboratories, and pharmaceutical companies, particularly in regions dependent on imports such as Asia-Pacific and Latin America. High-value segments like ultra-low temperature freezers, cryogenic freezers, and vaccine storage refrigerators are most affected due to dependence on global supply chains. However, tariffs are also encouraging local manufacturing of refrigeration systems, regional component sourcing, and investment in domestic cold chain infrastructure, strengthening long-term market resilience and supply security.
The biomedical refrigerator and freezer market research report is one of a series of new reports from The Business Research Company that provides biomedical refrigerator and freezer market statistics, including biomedical refrigerator and freezer industry global market size, regional shares, competitors with a biomedical refrigerator and freezer market share, detailed biomedical refrigerator and freezer market segments, market trends and opportunities, and any further data you may need to thrive in the biomedical refrigerator and freezer industry. This biomedical refrigerator and freezer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biomedical refrigerator and freezer market size has grown rapidly in recent years. It will grow from $4.34 billion in 2025 to $4.8 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing demand for vaccine storage during global immunization programs, rising need for reliable blood and plasma storage in hospitals, growth of pharmaceutical research requiring controlled temperature storage, expansion of clinical laboratories and diagnostic infrastructure, development of early cold chain logistics systems for healthcare supply chains.
The biomedical refrigerator and freezer market size is expected to see rapid growth in the next few years. It will grow to $7.25 billion by 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to rising demand for biologics and cell based therapies requiring ultra low temperature storage, increasing focus on vaccine distribution and pandemic preparedness infrastructure, growing adoption of smart monitoring and connected refrigeration systems, expansion of biobanking and genomic research requiring long term sample preservation, increasing regulatory standards for temperature sensitive medical storage. Major trends in the forecast period include IoMT enabled biomedical refrigeration systems with real time temperature monitoring and predictive alerts, energy efficient ultra low temperature freezer designs reducing operational carbon footprint, cloud based cold chain monitoring platforms for vaccine and biologics storage management, automated inventory and sample tracking integration in biomedical storage systems, advanced insulation and cryogenic cooling technologies for extended biological preservation.
The increasing clinical trial activities are expected to propel the growth of the biomedical refrigerator and freezer market going forward. Clinical trial activities encompass the planning, conduct, monitoring, and analysis of research studies aimed at evaluating the safety, efficacy, and outcomes of medical interventions in human participants. The rising clinical trial activities are being driven by the growing demand for innovative therapies, as pharmaceutical and biotechnology companies are increasingly undertaking studies to develop new drugs and treatments that address unmet medical needs across global markets. The expansion of clinical trials is contributing to a higher requirement for biomedical refrigerators and freezers, as a growing volume of biological samples, vaccines, and experimental drugs must be maintained under strict controlled temperature conditions to preserve their safety, stability, and effectiveness. For instance, in March 2026, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, the UK recorded a 36% increase in the number of commercial clinical trials launched in 2024 compared to the previous year, advancing two positions to rank sixth globally in competitiveness for all Phase III trials initiated during that year. Therefore, the increasing clinical trial activities are significantly propelling the growth of the biomedical refrigerator and freezer market.
Leading companies operating in the biomedical refrigerators and freezers market are focusing on developing advanced solutions, such as ultra-low temperature (ULT) freezers, to enhance sample preservation, improve workflow efficiency, and support regulatory compliance in laboratory and clinical settings. Ultra-low temperature (ULT) freezers refer to refrigeration systems capable of maintaining extremely low temperatures (typically -40°C to -86°C) for the storage of biological materials, pharmaceuticals, and cell- and gene-therapy products. For example, in April 2024, Thermo Fisher Scientific Inc., a US-based life sciences technology company, launched the TSX Universal Series ULT Freezers. Designed to assist scientists across diverse workflows, the freezers feature Universal V-Drive technology, tighter temperature control, faster recovery times, and universal voltage support, while achieving ISO Class 5.5 cleanroom compliance. These enhancements enable reliable long-term storage of blood, blood products, and sensitive biological materials in academic, GMP, and research laboratories, while improving energy efficiency and supporting sustainability goals.
In December 2025, AddLife AB, a Sweden-based life science and laboratory technology company, acquired Pharmacold A/S for an undisclosed amount. Through this acquisition, AddLife intends to expand its biomedical refrigeration and cold storage offerings, enhancing its service capabilities and providing advanced, temperature-controlled solutions for the pharmaceutical, healthcare, and research sectors. Pharmacold A/S is a Denmark-based company that designs, installs, and services customized refrigeration and freezer systems for pharmaceutical and healthcare applications.
Major companies operating in the biomedical refrigerator and freezer market are Thermo Fisher Scientific Inc., Liebherr Group, Follett LLC, Dometic Group, PHC Holdings Corporation, Eppendorf AG, Telstar SA, Binder GmbH, B Medical Systems S. a r. l., Helmer Inc., Vestfrost Solutions, Arctiko A/S, Jeio Tech Inc., So-Low Environmental Equipment Co. Inc., Migali Industries Inc., Desmon S. p. A., Labcold Ltd., Philipp Kirsch GmbH, Gram Commercial A/S, Haier Biomedical International, Fiocchetti Scientific S. r. l., Evermed S. r. l., Accucold, Froilabo
North America was the largest region in the biomedical refrigerator and freezer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomedical refrigerator and freezer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the biomedical refrigerator and freezer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biomedical refrigerator and freezer market consists of sales of CO2 incubator-compatible refrigerators, ice-lined refrigerators, portable biomedical freezers, and alarmed refrigerators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biomedical Refrigerator And Freezer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses biomedical refrigerator and freezer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biomedical refrigerator and freezer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomedical refrigerator and freezer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.